稳态性肝病的分类是动态的,影响临床试验资格和子类特定治疗
Mads Israelsen1, Katrine Holtz Thorhauge1, Peter Andersen2
1Centre for Liver Research, Department of Gastroenterology and Hepatology, Odense University Hospital, Odense, Denmark; Institute of Clinical Research, University of Southern Denmark, Odense, Denmark.
概括
脂肪性肝病 (SLD) 和其亚型的诊断非常动态,许多人在两年内改变分类. 饮酒量和肝脂肪的变化对SLD的诊断和管理有重大影响.
科学领域:
- 肝病学 肝病学是一种肝病学.
- 胃肠病学 胃肠病学
- 内部医学 内部医学
背景情况:
- 脂肪性肝病 (SLD) 涵盖了与代谢功能障碍相关的脂肪性肝病,代谢性和与酒精有关的肝病以及与酒精有关的肝病.
- 随着时间的推移,SLD诊断的稳定性对于患者管理和临床试验资格至关重要.
研究的目的:
- 在两年时间内调查脂肪性肝病 (SLD) 诊断和分类的稳定性和稳定性.
- 评估改变生活方式因素对SLD分类的影响.
主要方法:
- 进行了一项前性队列研究,包括来自普通人群的参与者和那些有SLD风险的人.
- 参与者根据SLD诊断标准在基线被分类,并在两年后重新评估.
主要成果:
- 在1042名参与者中,38%的人在两年内改变了他们的SLD分类.
- 在代谢性和与酒精有关的肝病 (62%) 和与酒精有关的肝病 (69%) 的个体中经常观察到变化.
- 改变分类的主要原因包括不再符合SLD标准或改变酒精摄入量.
结论:
- 脂肪性肝病 (SLD) 和其分类是动态的,特别受酒精消费和肝脏脂肪症的影响.
- SLD的波动性影响临床试验的资格,并需要适应性患者管理策略.
相关概念视频
Clinical Trials: Overview
2.5K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
2.5K
Clinical Trials
6.6K
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
There are four phases in a clinical trial. A phase one...
6.6K
Physiological Pharmacokinetic Models: Incorporating Hepatic Transporter-Mediated Clearance
20
Drug transporters are critical in drug absorption, distribution, and excretion processes. They should be included in physiological-based pharmacokinetic (PBPK) models, which help predict human drug disposition. However, predicting this is challenging during drug development, especially when liver transport is involved. However, with a realistic representation of body transport processes, an accurate model may be possible.
A recent model describes pravastatin's hepatobiliary excretion,...
A recent model describes pravastatin's hepatobiliary excretion,...
20
Hepatic Drug Clearance: Role of Transporters
28
In the liver and bile canaliculi, influx and efflux transporters modification can influence intrinsic clearance. Transporters play a significant role in moving drugs within liver cells. Elaborate models, such as the Biopharmaceutical Classification System (BCS), are essential to relate transporters to drug disposition. This system categorizes drugs into four classes based on solubility and permeability, providing insights into elimination routes and the effects of transporters following oral...
28
Liver Physiology
391
The liver, an essential organ in the human body, performs over 200 vital functions that can be broadly categorized into metabolic, hematological, endocrine regulation, and bile production.
Metabolic Regulation:
The liver is the central organ involved in regulating blood composition. It stabilizes blood glucose levels, maintaining them within the range of 70–110 mg/dL. When these levels drop, the liver breaks down glycogen reserves and releases glucose into the bloodstream. It can...
Metabolic Regulation:
The liver is the central organ involved in regulating blood composition. It stabilizes blood glucose levels, maintaining them within the range of 70–110 mg/dL. When these levels drop, the liver breaks down glycogen reserves and releases glucose into the bloodstream. It can...
391
Ultrasound II: Endoscopic Ultrasound and FibroScan
59
Endoscopic Ultrasound (EUS) and FibroScan are valuable diagnostic tools in gastroenterology and hepatology, each with specific applications and techniques.
Endoscopic Ultrasound (EUS):
Endoscopic Ultrasound (EUS):
59


